Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 23

1.

Interobserver variability in the delineation of the primary lung cancer and lymph nodes on different four-dimensional computed tomography reconstructions.

Mercieca S, Belderbos JSA, De Jaeger K, Schinagl DAX, van der Voort Van Zijp N, Pomp J, Theuws J, Khalifa J, van de Vaart P, van Herk M.

Radiother Oncol. 2017 Dec 2. pii: S0167-8140(17)32737-8. doi: 10.1016/j.radonc.2017.11.020. [Epub ahead of print]

PMID:
29208512
2.

Quality of Life in Relation to Pain Response to Radiation Therapy for Painful Bone Metastases.

Westhoff PG, de Graeff A, Monninkhof EM, Pomp J, van Vulpen M, Leer JW, Marijnen CA, van der Linden YM; Dutch Bone Metastasis Study Group.

Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):694-701. doi: 10.1016/j.ijrobp.2015.06.024. Epub 2015 Jun 20.

PMID:
26281825
3.

[Paraneoplastic phenomena in patients with a thymoma].

Strijbos E, Pomp J, Gilhuis HJ.

Ned Tijdschr Geneeskd. 2013;157(34):A6122. Dutch.

PMID:
23965241
4.

Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial.

Nout RA, Smit VT, Putter H, Jürgenliemk-Schulz IM, Jobsen JJ, Lutgens LC, van der Steen-Banasik EM, Mens JW, Slot A, Kroese MC, van Bunningen BN, Ansink AC, van Putten WL, Creutzberg CL; PORTEC Study Group.

Lancet. 2010 Mar 6;375(9717):816-23. doi: 10.1016/S0140-6736(09)62163-2.

PMID:
20206777
5.

Multiinstitutional study on target volume delineation variation in breast radiotherapy in the presence of guidelines.

van Mourik AM, Elkhuizen PH, Minkema D, Duppen JC; Dutch Young Boost Study Group, van Vliet-Vroegindeweij C.

Radiother Oncol. 2010 Mar;94(3):286-91. doi: 10.1016/j.radonc.2010.01.009. Epub 2010 Mar 2.

PMID:
20199818
6.

Outcome of radiotherapy in T1 glottic carcinoma: a population-based study.

Sjögren EV, Wiggenraad RG, Le Cessie S, Snijder S, Pomp J, Baatenburg de Jong RJ.

Eur Arch Otorhinolaryngol. 2009 May;266(5):735-44. doi: 10.1007/s00405-008-0803-9. Epub 2008 Oct 7.

PMID:
18839197
7.

Three-dimensional (3D) reconstruction and quantitative analysis of the microvasculature in medulloblastoma and ependymoma subtypes.

Gilhuis HJ, van der Laak JA, Pomp J, Kappelle AC, Gijtenbeek JM, Wesseling P.

Angiogenesis. 2006;9(4):201-8. Epub 2006 Nov 16.

PMID:
17109194
8.

[Neurological symptoms as the first sign of prostate carcinoma].

Gilhuis HJ, Otaredian I, Pomp J, Sillevis Smitt PA.

Ned Tijdschr Geneeskd. 2006 Apr 15;150(15):821-4. Dutch.

PMID:
16676509
9.

Analysis of local recurrence after breast conservative treatment for invasive breast cancer: a single institution cohort.

Pomp J, Blom J, Zwinderman AH, Sastrowijoto SH, van Krimpen C.

Oncol Rep. 2005 Nov;14(5):1255-61.

PMID:
16211293
11.

P53 and radiotherapy for oesophageal carcinoma: A comparison between 4 different antibodies.

Pomp J, Blom J, Zwinderman AH, Van Krimpen C.

Oncol Rep. 2000 Sep-Oct;7(5):1075-8.

PMID:
10948341
12.

The influence of the oncogene N-ras on cell cycle delay in a human melanoma cell line with reduced radioresistance.

Pomp J, Ouwerkerk IJ, Hoogstraten C, Wondergem J, Davelaar J, Leer JW, Schrier PI.

Oncol Rep. 2000 May-Jun;7(3):663-7.

PMID:
10767387
13.

The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study.

Steenland E, Leer JW, van Houwelingen H, Post WJ, van den Hout WB, Kievit J, de Haes H, Martijn H, Oei B, Vonk E, van der Steen-Banasik E, Wiggenraad RG, Hoogenhout J, Wárlám-Rodenhuis C, van Tienhoven G, Wanders R, Pomp J, van Reijn M, van Mierlo I, Rutten E.

Radiother Oncol. 1999 Aug;52(2):101-9. Erratum in: Radiother Oncol 1999 Nov;53(2):167. Leer, J [corrected to Leer, JW]; van Mierlo ,T [corrected to van Mierlo, I].

PMID:
10577695
14.

E-cadherin expression in oesophageal carcinoma treated with high-dose radiotherapy; correlation with pretreatment parameters and treatment outcome.

Pomp J, Blom J, van Krimpen C, Zwinderman AH, Immerzeel JJ.

J Cancer Res Clin Oncol. 1999 Nov;125(11):641-5.

PMID:
10541972
15.
16.

Pleomorphic adenoma and severe tracheal obstruction.

Pomp J, Pannekoek BJ, Overdiep SH.

Respir Med. 1998 Jun;92(6):889-91. No abstract available.

17.

Radiotherapy for oesophagus carcinoma: the impact of p53 on treatment outcome.

Pomp J, Davelaar J, Blom J, van Krimpen C, Zwinderman A, Quint W, Immerzeel J.

Radiother Oncol. 1998 Feb;46(2):179-84.

PMID:
9510045
18.

[Three scenarios of labor supply for the next 25 years].

Pomp JM.

Maandstat Bevolking. 1997 Jun;45(6):19-23. Dutch.

PMID:
12293413
19.

The influence of the oncogenes NRAS and MYC on the radiation sensitivity of cells of a human melanoma cell line.

Pomp J, Ouwerkerk IJ, Hermans J, Wondergem J, Cornelisse CJ, Leer JW, Schrier PI.

Radiat Res. 1996 Oct;146(4):374-81.

PMID:
8927709
20.

Cell density dependent plating efficiency affects outcome and interpretation of colony forming assays.

Pomp J, Wike JL, Ouwerkerk IJ, Hoogstraten C, Davelaar J, Schrier PI, Leer JW, Thames HD, Brock WA.

Radiother Oncol. 1996 Aug;40(2):121-5.

PMID:
8884965

Supplemental Content

Loading ...
Support Center